The Latest Breaking News from FDA

US launches major vaccination campaign in a bid to prevent healthcare strain and potential mutations of H5N1 virus

An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using MDMA, a synthetic compound known on the street as “ecstasy” or “molly.” A stay-at-home mom tries LSD, otherwise known as…

FDA-approved Shield blood test offers a convenient and effective screening option for colorectal cancer, improving early detection rates.

For men, FDA-approved medications like Minoxidil, the generic for Rogaine®, offer a safe and effective solution for hair loss.

The European Union (EU) has announced a 32 million euro initiative aimed at enhancing vaccine production in Ghana. The announcement was made during the Ghana-EU Business Forum held in Accra.

FDA warns of lead contamination in ground cinnamon sold at discount stores. Consumers advised to discard affected products to avoid health risks.

Overdoses may have arisen from patients with poor knowledge of drug measurements and medical equipment, such as syringes, according to public health officials

Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.

Scientists hope a new blood test for colorectal cancer could improve screening rates.

With the FDA's approval, it is very likely that private insurance companies and Medicare will cover the cost of the blood test, making it more accessible for patients.

A rise in counterfeit versions of sought-after weight loss drug has led to a series of hospitalisations.